Sign Up to like & get
recommendations!
0
Published in 2022 at "Scandinavian Journal of Rheumatology"
DOI: 10.1080/03009742.2021.2014105
Abstract: Mucocutaneous ulceration is one of the hallmark manifes-tations of Behçet’s disease (BD). Interleukin-17A (IL-17A) inhibitors have been indicated in mucocutaneous lesions refractory to conventional therapy in patients with BD (1). IL-17A inhibitors have also proved…
read more here.
Keywords:
behcet like;
patient treated;
disease;
like disease ... See more keywords